I, K., S, S., DP, W., CA, T., A, B., H, Z., . . . SK, B. (2024). Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial. JAMA psychiatry, 81(8), 749. https://doi.org/10.1001/jamapsychiatry.2024.0785
Chicago Style (17th ed.) CitationI, Kaul, Sawchak S, Walling DP, Tamminga CA, Breier A, Zhu H, Miller AC, Paul SM, and Brannan SK. "Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial." JAMA Psychiatry 81, no. 8 (2024): 749. https://doi.org/10.1001/jamapsychiatry.2024.0785.
MLA (9th ed.) CitationI, Kaul, et al. "Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial." JAMA Psychiatry, vol. 81, no. 8, 2024, p. 749, https://doi.org/10.1001/jamapsychiatry.2024.0785.